Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ZUUXN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Ramucirumab-IR700 conjugate
|
|||||
| Synonyms |
Ramucirumab-IR700 conjugate (Jikei University School of Medicine)
Click to Show/Hide
|
|||||
| Organization |
Jikei University
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Non-small cell lung cancer [ICD11:2C25]
Clinical candidate
|
|||||
| Antibody Name |
Ramucirumab
|
Antibody Info | ||||
| Antigen Name |
Vascular endothelial growth factor receptor 2 (KDR)
|
Antigen Info | ||||
| Payload Name |
IRDye 700DX
|
Payload Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through nucleophilic lysines.
|
|||||
| Combination Type |
Sarotalocan
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.